This US single family office invests in life sciences [2022]

This US single family office invests in life sciences [2022]

This article directly stems from the research process for our single family office database. Our list of life science focused single family offices includes the most important family investment vehicles that invest in life sciences and biotech. The list is based on a keyword crawler that analyzes our global list.

You might also like the list of the 700 largest biotech venture capital investors, created by our partner portal ThousandInvestors.

Arie Belldegrun is an Israeli-American billionaire that has launched and invested in various pharma companies. The Tel-Aviv born entrepreneur is, for instance, founder of Agensys, which was sold to Astellas Pharma in 2007. Since 2003, Belldegrun is investing – together with his wife Rebecka Belldegrun – in various sectors through their family office Bellco Capital. Amongst the target sectors is the life science industry. In January 2021, the life science-focused family office Bellco Capital invested in IconOVir. The firm develops a platform for oncolytic viruses that lead to anti-cancer responses and rapid tumor killing. Another investment of the pharma investor family office is UroGen Pharma, that works on non-surgical treatments for uro-oncology. 

Picture source: National Cancer Institute

Share this post

Leave a Reply

Your email address will not be published. Required fields are marked *